Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet J Maguire

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Life Sciences|February 23, 2016
Evidence for biased agonists and antagonists at the endothelin receptorsJanet J Maguire
Methods in Molecular Biology (Clifton, N.J.)|August 3, 2002
Endothelin-converting enzyme activity in vascular smooth muscle preparations in vitroJanet J Maguire
Current Opinion in Pharmacology|April 12, 2003
Discovering orphan receptor function using human in vitro pharmacologyJanet J Maguire
Trends in Pharmacological Sciences|April 5, 2002
Of mice and men: advances in endothelin research and first antagonist gains FDA approvalAnthony P Davenport, Janet J Maguire
British Journal of Pharmacology|October 17, 2002
Is urotensin-II the new endothelin?Janet J Maguire, Anthony P Davenport
Trends in Pharmacological Sciences|August 2, 2005
Regulation of vascular reactivity by established and emerging GPCRsJanet J Maguire, Anthony P Davenport
Seminars in Nephrology|May 13, 2015
Endothelin receptors and their antagonistsJanet J Maguire, Anthony P Davenport
Contributions to Nephrology|September 7, 2011
Pharmacology of renal endothelin receptorsAnthony P Davenport, Janet J Maguire
British Journal of Pharmacology|November 29, 2011
Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancerLowell Ling, Janet J Maguire, Anthony P Davenport
Trends in Pharmacological Sciences|July 6, 2015
Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular systemPeiran Yang, Janet J Maguire, Anthony P Davenport
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Life Sciences|February 23, 2016
Evidence for biased agonists and antagonists at the endothelin receptorsJanet J Maguire
Methods in Molecular Biology (Clifton, N.J.)|August 3, 2002
Endothelin-converting enzyme activity in vascular smooth muscle preparations in vitroJanet J Maguire
Current Opinion in Pharmacology|April 12, 2003
Discovering orphan receptor function using human in vitro pharmacologyJanet J Maguire
Trends in Pharmacological Sciences|April 5, 2002
Of mice and men: advances in endothelin research and first antagonist gains FDA approvalAnthony P Davenport, Janet J Maguire
British Journal of Pharmacology|October 17, 2002
Is urotensin-II the new endothelin?Janet J Maguire, Anthony P Davenport
Trends in Pharmacological Sciences|August 2, 2005
Regulation of vascular reactivity by established and emerging GPCRsJanet J Maguire, Anthony P Davenport
Seminars in Nephrology|May 13, 2015
Endothelin receptors and their antagonistsJanet J Maguire, Anthony P Davenport
Contributions to Nephrology|September 7, 2011
Pharmacology of renal endothelin receptorsAnthony P Davenport, Janet J Maguire
British Journal of Pharmacology|November 29, 2011
Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancerLowell Ling, Janet J Maguire, Anthony P Davenport
Trends in Pharmacological Sciences|July 6, 2015
Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular systemPeiran Yang, Janet J Maguire, Anthony P Davenport
Pageof 9